Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK

https://doi.org/10.20996/1819-6446-2016-12-3-272-276

Full Text:

Abstract

Aim. To assess the impact of metabolic abnormalities in combination with obstructive sleep apnea on endothelial function and vascular stiffness parameters in patients with arterial hypertension 1-2 degrees. Material and methods. Patients (n=74) with metabolic syndrome and obstructive sleep apnea were included into the study. All patients underwent cardiorespiratory monitoring of sleep using SomnoCheck2 device (Wiennmann, Germany) and were divided into two groups based on its results. Patients with apnea-hypopnea index (AHI) <30 episodes per hour were included into group 1 and patients with AHI >30 episodes per hour – into group 2. Monitoring of ambulatory blood pressure (BP) and arterial stiffness was performed by the device BPLab ("Peter Telegin", Russia). Endothelial function was assessed in a probe of flow-mediated dilation by the ultrasound device MyLab 90 (Esaote, Italy). Diameter of the common carotid artery (DCCA) and the intima-media thickness (IMT) were determined. Results. Patients with AHI >30 episodes per hour had higher mean daily and night systolic BP and pulse BP in aorta and brachial artery. Pulse wave velocity in aorta in per day averaged was also higher in these patients (8.2±0.8 vs 9.1±1.1 m/sec; p<0.05). Mean level of flow-mediated dilation was significantly lower in patients with severe sleep apnea> (8.8% (5.6; 13.1) vs 4.5% (2.2; 8.0); p<0.05). Prevalence of negative index of reactivity in group 2 was 2 times higher than this in group 1. An increase in IMT and DCCA in patients with severe obstructive sleep apnea was also revealed. Conclusion. Severe sleep apnea in patients with metabolic syndrome in combination with hypertension aggravates structural changes and endothelial dysfunction of the main arteries, as well as contributes to the progression of atherosclerosis.

About the Authors

V. E. Oleynikov
Penza State University. Krasnaya ul. 40, Penza, 440026 Russia
Russian Federation


N. V. Burko
Penza State University. Krasnaya ul. 40, Penza, 440026 Russia
Russian Federation


L. I. Salyamova
Penza State University. Krasnaya ul. 40, Penza, 440026 Russia
Russian Federation


K. A. Ziboreva
Penza State University. Krasnaya ul. 40, Penza, 440026 Russia
Russian Federation


References

1. Stehouwer C. D. A., Henry R. M. A., Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51:527-39.

2. Chung S., Yoon I. Y., Lee C. H. et al. The association of nocturnal hypoxemia with arterial stiffness and endothelial dysfunction in male patients with obstructive sleep apnea syndrome. Respiration 2010; 79(5):363-9.

3. Huang R, Xiao Y, Zhong X, et al. Roles of hypertension and serum leptin in obstructive sleep apnea hypopnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2010; 32:157-61.

4. National guidelines on the diagnosis and treatment of metabolic syndrome. The second revision. Kardiovaskulyarnaya Terapiya i Profilaktika 2007; 6 (6) suppl 2: 1-27. In Russian (Национальные рекомендации по диагностике и лечению метаболического синдрома. Второй пересмотр. Кардиоваскулярная терапия и профилактика 2007;6 (6) Приложение 2: 1-27.).

5. User guide SW BPLab V.3.2. Part 1. 2011; 149. In Russian (Руководство пользователя ПО BPLab V. 3.2. Часть 1. 2011; 149).

6. Celermajer D. S., Sorensen K. E., Gooch V. M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-5.

7. Glanz C. Biomedical statistics. Мoscow: Praktika; 1999. In Russian (Гланц С. Медико-биологическая статистика. М.: Практика; 1999).

8. Litvin A.U., Chazova I.E., Galyavi R.A. Obstructive sleep apnea and metabolic syndrome. Doktor.ru 2007; (4):5-9. In Russian (Литвин А.Ю., Чазова И.Е., Галяви Р.А. Обструктивное апноэ сна и метаболический синдром. Доктор.ру 2007; (4):5-9).

9. O’Connor G. T., Caffo B., Newman A. B. et al. Prospective study of the association between sleep-disordered breathing and hypertension: the Sleep Heart Health Study. American journal of respiratory and critical care medicine 2009; 179(12):1159-64.10. Levin Y.I, Poluektov M.G. Somnology and sleep medicine. Selected lectures Moscow: MedForum; 2013. In Russian (Левин Я.И., Полуэктов М.Г. Сомнология и медицина сна. Избранные лекции М.: Медфорум; 2013).

10. Volov N.A., Shaidyuk O.Y., Taratukhin E.O. Sleep apnea syndrome and risk factors for cardiovascular diseases. Rossiyskiy Kardiologicheskiy Zhurnal 2008; (3):65-70. In Russian (Волов Н.А., Шайдюк О.Ю., Таратухин Е.О. Синдром ночного апноэ и факторы риска сердечно-сосудистой патологии. Российский Кардиологический Журнал 2008; (3):65-70).

11. Shiina K., Tomiyama H., Takata Y. et al. Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk. A sleep clinic cohort study. Hypertens Res 2006; 29:433-41.

12. Doonan R., Scheffler P., Marek L. et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertension Research 2011; 34:23-32.

13. Vlachantoni I.T., Dikaiakou E., Antonopoulos C.N. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep medicine reviews 2013; 17(1):19-28.


For citation:


Oleynikov V.E., Burko N.V., Salyamova L.I., Ziboreva K.A. EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK. Rational Pharmacotherapy in Cardiology. 2016;12(3):272-276. https://doi.org/10.20996/1819-6446-2016-12-3-272-276

Views: 314


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)